-

SHAREHOLDER ALERT: Robbins LLP Announces That Arcimoto (FUV) is Being Sued for Misleading Shareholders

SAN DIEGO & EUGENE, Ore.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Arcimoto Inc. (NASDAQ: FUV) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between February 14, 2018 and March 22, 2021. Acrimoto purportedly manufactures ulta-efficient three-wheeled electric vehicle.

If you suffered a loss due to Arcimoto Inc.'s misconduct, click here.

Arcimoto Inc. (FUV) Misled Investors Regarding its Business Operations

According to the complaint, Arcimoto stated in press releases from 2018 to 2020 that they had received 400 preorders for their Fun Utility Vehicle. Arcimoto generated excitement for their vehicles by announcing pilot programs with various entities, including HULA Holdings, GoCar Tours, and Sol Mar Vida. On October 2, 2019, Arcimoto announced its first rental franchise to open in the Florida Keys. Arcimoto subsequently announced a municipal pilot program with the Eugene Springfield Fire Department and the City of Orlando. However, these statements were false and misleading.

On March 23, 2021, Bonitas Research published a report revealing that Arcimoto had misled the investing public by fabricating its preorders. Specifically, the report claims that Arcimoto only delivered 5% if its pre-orders. The report further stated that Arcimoto filed a total production recall notice with the National Highway Traffic Safety Administration on November 18, 2020, but "concealed safety concerns from customers and investors." The report also revealed several related party transactions, specifically with R-Key-Moto the Florida Keys franchise, Wahlbergers Key West, and HULA. On this news, Arcimoto's stock fell approximately 6.56% to close at $15.67 per share on March 23, 2021, damaging investors. The stock has continued to decline and now trades at just over $10 per share.

If you purchased shares of Arcimoto Inc. (FUV) between February 14, 2018 and March 22, 2021, you have until June 18, 2021, to ask the court to appoint you lead plaintiff for the class. If you would like more information regarding your rights, please contact Lauren Levi at (800) 350-6003 or llevi@robbinsllp.com, or via our Shareholder Information Form.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Arcimoto Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...
Back to Newsroom